Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB

• Published in: Toxicology (Amsterdam) 2006-03, Vol.220 (2), p.104-116
• Main Authors: Ceccatelli, Raffaella, Faass, Oliver, Schlumpf, Margret, Lichtensteiger, Walter
• Format: Article
• Language: English
• Subjects: Adipose Tissue - chemistry; Animals; Biological and medical sciences; Chlorodiphenyl (54% Chlorine) - toxicity; Development; Estradiol - pharmacology; Estrogen Receptor alpha - genetics; Estrogen Receptor alpha - metabolism; Estrogen Receptor beta - genetics; Estrogen Receptor beta - metabolism; Estrogen sensitivity; Female; Gene expression; Gene Expression Regulation - drug effects; Halogenated Diphenyl Ethers; Insulin-Like Growth Factor I - genetics; Insulin-Like Growth Factor I - metabolism; Medical sciences; mRNA; Ovariectomy; Phenyl Ethers - blood; Phenyl Ethers - pharmacokinetics; Phenyl Ethers - toxicity; Polybrominated Biphenyls - blood; Polybrominated Biphenyls - pharmacokinetics; Polybrominated Biphenyls - toxicity; Polybrominated diphenylether (PBDE); Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Long-Evans; Receptors, Progesterone - genetics; Receptors, Progesterone - metabolism; RNA, Messenger - metabolism; Toxicology; Uterus; Uterus - drug effects; Uterus - metabolism
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2005.12.004

Considering the presence of polybrominated diphenylethers (PBDEs) in human milk and cord blood, and the estrogenic activity of some congeners, it is conceivable that PBDEs may interact with developing neuroendocrine systems. We investigated effects of 2,2′,4,4′,5-pentabromo-DE (PBDE 99), a major congener in human milk, on development of brain and reproductive organs, with focus on estrogen target gene expression. Time-pregnant Long Evans rats were subcutaneously injected with PBDE 99 (1 or 10 mg/kg/day), the PCB mixture Aroclor 1254 (10 mg/kg/day), known to interfere with sexual development, or vehicle, from gestational day (GD) 10 to GD 18. In female offspring, anogenital distance was unaffected by PBDE 99 but increased by Aroclor; puberty (vaginal opening) was not significantly changed. Adult PBDE 99-exposed offspring exhibited unchanged uterine weight but increased ovarian weight. Uterine mRNA levels of estrogen target genes were determined by real-time PCR. Progesterone receptor (PR) mRNA was down-regulated at both PBDE 99 doses, estrogen receptor alpha (ER alpha), ER beta and insulin-like growth factor-I (IGF-I) were up-regulated at the lower dose. Aroclor induced different effect patterns. In order to investigate possible changes in sensitivity of target genes to estrogen, some offspring were ovariectomized at 10 weeks of age, s.c. injected with estradiol-17β (E2, 10 μg/kg) or vehicle at 12 weeks, and sacrificed 6 h later. PBDE 99 dose-dependently reduced the magnitude of IGF-I mRNA induction by E2, and increased the magnitude of ER beta repression. PBDE 99 also influenced baseline levels of PR, IGF-I and ER beta mRNAs in ovariectomized, vehicle-injected controls. These data indicate that developmental exposure to PBDE 99 at doses devoid of general toxicity, affects the regulation of estrogen target genes in uterus. Since PBDE 99 was detected in blood and adipose tissue of adult offspring, these effects may result from interactions with developmental processes, adult functions, or a combination of both.